Avak Kahvejian, Abiologics CEO
July 23, 2024 06:00 AM EDTUpdated 06:24 AM
Financing
Startups
R&D

Flag­ship launch­es AI-pow­ered bi­o­log­ics biotech with $50M back­ing

Ayisha Sharma

News Reporter

Flag­ship Pi­o­neer­ing has un­veiled a new biotech that’s on a mis­sion to build a new class of bi­o­log­ics with the help of AI.

Abi­o­log­ics, which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times